Vanderbilt Clinical Oncology Research Career Development Award

项目摘要 范德比尔特临床肿瘤学研究职业发展计划（VCORCDP）提供初级教师 开展以患者为导向的癌症研究，提供设计和实施的工具和经验 假设驱动的研究和有效地领导癌症研究项目。该计划是一个基石， 范德比尔特英格拉姆癌症中心（VICC），其活动嵌入整个VICC企业， 培训与癌症相关的各个专业的主要研究人员。该计划确保我们开发一个 强大而多样化的新兴调查人员渠道，他们拥有推动有影响力的 计划，谁已经加快了他们的轨迹，多学科和社区参与 专注学习。VCORCDP的主要组成部分是指导临床研究在肿瘤学耦合 量身定制的教学培训，可能导致临床研究或其他批准的科学硕士 个性化的教育途径和团体技能发展，接触癌症的广度 research.我们的导师是一个多元化的39承诺，经验丰富的教师组。学者进行研究 在三个领域之一的癌症护理连续体中：1）临床试验和药物开发，2） 转化癌症生物学，和3）癌症健康结果和流行病学。通过定期会议 与项目主任，同行学者和导师委员会，以及个人的准备 发展计划和结构化的进度报告，VCORCDP学者量身定制他们的职业发展， 能够解决其领域中最相关和最有意义的问题。该项目由两名 医生科学家，进行转化研究的医学肿瘤学家和 进行人口科学和临床研究。内部咨询委员会代表的多样性 VCORCDP的研究评估个别学者的进展和该计划的成功。度量 包括项目参与者多样性、项目完成情况、保留以研究为重点的职业、资金 成功、出版和影响。一个外部咨询委员会，由一名癌症流行病学家、 社区代表和四名肿瘤学医生-科学家为以下科学方向提供了投入： 计划，确保它满足国家劳动力需求和癌症优先事项，并监测进展， 成就和进一步推进方案的轨迹。五十六名学者已进入 VCORCDP自成立以来，男性占57%，女性占43%。截至2021年6月，7名学者（12%）代表 URiM集团。我们的56位学者在他们的职业生涯中发表了1,800多篇手稿。的50 在已经毕业的学者中，45人（90%）继续从事研究密集型职业，45人中的38人（84%） 同行评审的赠款支持，包括临床试验。VCORCDP准备继续成功地 培养研究人员，以领导以患者为导向的癌症研究和推进癌症护理。

PROJECT SUMMARY The Vanderbilt Clinical Oncology Research Career Development Program (VCORCDP) provides junior faculty conducting patient-oriented research in cancer with the tools and experience to design and implement hypothesis-driven research and effectively lead cancer research projects. This program is a cornerstone of the Vanderbilt Ingram Cancer Center (VICC), and its activities are embedded across the entire VICC enterprise, training leading investigators from every specialty related to cancer. This program ensures that we develop a strong and diverse pipeline of emerging investigators who have the skills necessary to drive impactful programs, and who have been accelerated in their trajectory by multidisciplinary and community-engaged focused learning. The primary components of VCORCDP are mentored clinical research in oncology coupled with tailored didactic training that may lead to a Master of Science in Clinical Investigation or other approved individualized educational pathway and group skill development, with exposure to the breadth of cancer research. Our mentors are a diverse group of 39 committed, experienced faculty. Scholars conduct research across the cancer care continuum in one of three domains: 1) Clinical Trials and Drug Development, 2) Translational Cancer Biology, and 3) Cancer Health Outcomes and Epidemiology. Through regular meetings with the Program Directors, peer scholars, and mentorship committees, as well as preparation of Individual Development Plans and structured Progress Reports, VCORCDP scholars tailor their career development to be able to address the most relevant and meaningful issues in their field. The program is co-led by two physician scientists, a medical oncologist who conducts translational research and a pediatric oncologist who conducts population science and clinical research. An Internal Advisory Committee representing the diversity of VCORCDP research evaluates the progress of individual scholars and the program’s success. Metrics include diversity of program participants, program completion, retention in research-focused careers, funding success, publication, and impact. An External Advisory Committee, composed of a cancer epidemiologist, a community representative, and four oncology physician-scientists, provides input into the scientific direction of program, ensures it is meeting national workforce needs and cancer priorities, and monitors progress, accomplishments, and trajectory to further programmatic advancement. Fifty-six scholars have entered the VCORCDP since its inception, 57% male and 43% female. As of June 2021, seven scholars (12%) represent URiM groups. Our 56 scholars have published over 1,800 manuscripts over their careers to date. Of the 50 scholars who have graduated, 45 (90%) continue in research-intensive careers, and 38 of the 45 (84%) have peer-reviewed grant support, including clinical trials. The VCORCDP is poised to continue to successfully develop investigators to lead patient-oriented cancer research and advance cancer care.